Drug Shortage Report for TOBRAMYCIN INHALATION SOLUTION
| Report ID | 2553 |
| Drug Identification Number | 02443368 |
| Brand name | TOBRAMYCIN INHALATION SOLUTION |
| Common or Proper name | TOBRAMYCIN |
| Company Name | SANDOZ CANADA INCORPORATED |
| Market Status | CANCELLED POST MARKET |
| Active Ingredient(s) | TOBRAMYCIN |
| Strength(s) | 300MG |
| Dosage form(s) | SOLUTION |
| Route of administration | INHALATION |
| Packaging size | 5mL x 56 Amp |
| ATC code | J01GB |
| ATC description | AMINOGLYCOSIDE ANTIBACTERIALS |
| Reason for shortage | Requirements related to complying with good manufacturing practices. |
| Anticipated start date | |
| Actual start date | 2017-02-06 |
| Estimated end date | 2017-04-14 |
| Actual end date | 2017-05-15 |
| Shortage status | Resolved |
| Updated date | 2017-05-17 |
| Company comments | Stock available at some wholesalers/Inventaire disponible chez certains grossistes |
| Health Canada comments | |
| Tier 3 Status | No |
| Contact Address | 110 RUE DE LAUZON BOUCHERVILLE, QUEBEC CANADA J4B 1E6 |
| Company contact information | 1 800-361-3062 |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
| Version Number | Date Updated | Language | |
|---|---|---|---|
| v8 | 2017-05-17 | French | Compare |
| v7 | 2017-05-17 | English | Compare |
| v6 | 2017-03-28 | French | Compare |
| v5 | 2017-03-28 | English | Compare |
| v4 | 2017-03-21 | French | Compare |
| v3 | 2017-03-21 | English | Compare |
| v2 | 2017-03-14 | French | Compare |
| v1 | 2017-03-14 | English | Compare |
Showing 1 to 8 of 8